Related Experiment Video
Updated: Mar 17, 2026

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
Published on: May 10, 2022
Ubiquitin Ligase, Fbw7, Targets CDX2 for Degradation via Two Phosphodegron Motifs in a GSK3β-Dependent Manner
Yogesh Kumar1, Nidhi Shukla1, Gatha Thacker1
1Biochemistry Division, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, India.
Abstract:
Drosophila caudal-related homeobox transcription factor 2 (CDX2) drives differentiation of the intestinal epithelium. Loss of CDX2 expression has been reported in several colorectal cancers and cancer cell lines with a potential inverse correlation between CDX2 levels and tumor stage. Ubiquitination of CDX2 leading to its downregulation has been implicated in several studies; however, the E3 ubiquitin ligases involved in CDX2 ubiquitination have largely remained unknown. Here, it is mechanistically determined that the E3 ubiquitin ligase Fbw7 promotes CDX2 ubiquitination and degradation through two phosphodegron motifs present within CDX2 in a GSK3β-dependent manner leading to its reduced expression and function in colon cancer cells. Fbw7, through its WD domain, interacted with CDX2 both in a heterologous HEK293T cell system and in colon cancer cells. GSK3β was also present in the same complex as determined by coimmunoprecipitation. Furthermore, overexpression of both Fbw7 or GSK3β down regulated endogenous CDX2 expression and function; however, both failed to inhibit endogenous CDX2 when either of them were depleted in colon cancer cells. Fbw7-mediated inhibition of CDX2 expression also led to reduced CDX2 transactivation and growth arrest of colon cancer cells. Both GSK3β and Fbw7 degraded mutant-CDX2 having either of the Cdc4-phosphodegron (CPD) motifs disrupted (CDX2-S60A or CDX-S281A), but were unable to degrade mutant-CDX2 having both CPDs disrupted (CDX2-S60,64,281A).
Implications:
Taken together, these findings demonstrate that Fbw7 negatively regulates CDX2 expression in a GSK3β-dependent manner through two CPDs present in CDX2. Mol Cancer Res; 14(11); 1097-109. ©2016 AACR.
Insights
The E3 ubiquitin ligase Fbw7 targets CDX2 for degradation in colon cancer cells, dependent on GSK3β and phosphodegron motifs. This mechanism reduces CDX2 expression and function, inhibiting colon cancer cell growth.
Area of Science:
- Molecular biology
- Cancer research
- Cellular signaling
Background:
- CDX2 is crucial for intestinal epithelium differentiation.
- CDX2 loss correlates with colorectal cancer progression.
- E3 ubiquitin ligases targeting CDX2 remain largely unknown.
Purpose of the Study:
- To identify E3 ubiquitin ligases regulating CDX2.
- To elucidate the mechanism of CDX2 ubiquitination and degradation.
- To investigate the role of Fbw7 and GSK3β in colon cancer cell regulation.
Main Methods:
- Co-immunoprecipitation to detect protein interactions.
- HEK293T and colon cancer cell line experiments.
- Western blotting to assess protein levels and ubiquitination.
- Mutagenesis to disrupt phosphodegron motifs.
Main Results:
- Fbw7 directly ubiquitinates CDX2 via two phosphodegron motifs in a GSK3β-dependent manner.
- Fbw7 and GSK3β overexpression decrease CDX2 levels; depletion prevents this.
- Fbw7-mediated CDX2 degradation inhibits colon cancer cell growth and transactivation.
- Mutations in both phosphodegron motifs abolish CDX2 degradation.
Conclusions:
- Fbw7 negatively regulates CDX2 expression through GSK3β-dependent ubiquitination.
- This pathway is a key mechanism controlling CDX2 in colon cancer.
- Targeting Fbw7 or GSK3β may offer therapeutic strategies for colorectal cancer.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Anaphase Promoting Complex
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

